|KEYSTONE HEART ISRAEL||Vice President Quality and Regulatory Affairs||Israel|
| Big size vs mid-size companies: Different ways to deal with early-stage start-ups? |
My university education includes BSc. In computer science and biology, M.Sc. in Physiology and PhD in Neurophysiology, all from the Hebrew University in Jerusalem. Following which I went for post-doctorate in the University of Minnesota dept. of Physiology, studying the physiology of the retina. Since then I have been involved in six (6) different start-up medical device companies taking roles in R&D, system integrator and application manager, clinical research, quality and regulatory management including EU CE-marking, FDA and Canada. These small companies of 5 -20 employees were in the field of diabetes (continuous blood glucose monitoring), radiology – impedance imaging, Interventional cardiology – closure device and cerebral embolic protection, gastroenterology – imaging of the entire digestive system and ophthalmology – accommodating intra-ocular lens.